In 2000, Niino et al. determined the level of MIF in the cerebrospinal fluid (CSF) of patients with conventional-form multiple sclerosis (C-MS), optic-spinal form multiple sclerosis (OpS-MS), and neuro-Behcet's disease (NBD) [43]. The gene discussed is MIF; the disease is myeloid sarcoma.